On the upside
Samsung settled a lawsuit filed by Rambus (Nasdaq: RMBS) by agreeing to license Rambus technology. Rambus may potentially receive $900 million in the next five years.
Lexicon Pharmaceuticals (Nasdaq: LXRX) reported positive results from a Phase II clinical trial of its diabetes treatment LX4211.
Second quarter earnings for Cree (Nasdaq: CREE) more than tripled to surpass expectations.
On the downside
While fourth quarter earnings for CSX (NYSE: CSX) rose, shipping volume dropped and full year income fell.
Lexington Realty Trust (NYSE: LXP) will offer $100 million worth of convertible guaranteed notes.
Shares of eBay (Nasdaq: EBAY) fell ahead of its earnings release after market close.
In the broad market, declining issues outpaced advancers by a margin of nearly 4 to 1 on both the NYSE and on Nasdaq. The Russell 2000 which tracks small cap stocks tumbled 11 points to 637.
